Hpv

Including mid-adults in HPV vaccination efforts is safe and effective, while remaining cost effective, according to a narrative review of existing data.

Young survivors of pediatric cancers are at increased risk for a host of short-term and late health conditions, including HPV-related malignancies such as cervical and oropharyngeal cancers.

Medicaid covers HPV vaccination in individuals aged up to 45 years in 43 out of 50 states, according to a study.

PHILADELPHIA — Among women with systemic lupus erythematosus, just 3.7% are vaccinated for HPV, while nearly 30% demonstrate HPV infection, according to data presented at ACR Convergence 2022.

HPV vaccine uptake may improve if providers incorporate routine vaccination into postpartum care, according to research presented at the Infectious Diseases Society for Obstetrics and Gynecology meeting.

Recent findings suggest that with HPV tests, intervals between cervical screenings can be extended to 5 years after a negative result in women aged 25 to 49 years and even longer for women aged older than 50 years.

SAN DIEGO — Passively self-collected menstrual blood for the detection of HPV showed results that were highly concordant with clinician-collected sampling and had greater acceptance among patients, researchers reported here.

DENVER — Adolescents seen by a resident for preventive care were more than four times as likely to receive an HPV vaccination than those seen by a pediatric or advanced care practitioner attending alone, researchers reported.

The COVID-19 pandemic could reverse improvements made in recent decades toward HPV vaccination efforts, according to Mona Saraiya, MD, MPH.

High-grade vulvar, vaginal and anal precancer rates decreased or stabilized after the introduction of the HPV vaccine, according to findings published in the American Journal of Preventive Medicine.